FDA WARNING_LETTER - GYN Disposables, Inc. - April 12, 2011

On August 15, 2011, the FDA issued a Warning Letter to GYN Disposables, Inc. following an inspection from April 5-12, 2011, which found their IUD Insertion Kits and Endometrial Biopsy Kits to be adulterated. The devices were manufactured without conformity to Quality System (QS) regulation (21 CFR Part 820).

Key violations include: 1. **Lack of Process Validation (21 CFR 820.75(a)):** No documentation for validation of package/seal integrity or sterilization/packaging processes for sterile kits. 2. **Inadequate Supplier Controls (21 CFR 820.50(a)):** No documented controls for contract manufacturer's process monitoring, sterilization, or package sealing. Promised procedures and training were not submitted. 3. **Insufficient Acceptance Activities Procedures (21 CFR 820.80(a)):** Procedures for product release lacked specific instructions, acceptance criteria, test methods, and equipment details. 4. **Ineffective Corrective and Preventive Actions (CAPA) (21 CFR 820.100(a)(4)):** CAPA report #2005 noted lack of sterilization process data from the contract manufacturer, but no audit or further action was taken since 2008. 5. **Failure to Investigate Complaints (2